HK Stock MarketDetailed Quotes

LUK HING ENT (08052)

Watchlist
  • 0.041
  • 0.0000.00%
Market Closed Apr 30 09:20 CST
22.48MMarket Cap20.50P/E (TTM)

LUK HING ENT (08052) Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q6)Jun 30, 2025
(FY)Dec 31, 2024
(Q6)Jun 30, 2024
(FY)Dec 31, 2023
(Q6)Jun 30, 2023
(FY)Dec 31, 2022
(Q6)Jun 30, 2022
(FY)Dec 31, 2021
(Q6)Jun 30, 2021
(FY)Dec 31, 2020
Cash flow from operating activities
Earning before tax
----
-169.34%-11.16M
----
132.88%16.09M
----
39.96%-48.94M
----
-111.00%-81.51M
----
8.34%-38.63M
Profit adjustment
Interest (income) - adjustment
----
-8,700.00%-88K
----
83.33%-1K
----
14.29%-6K
----
-40.00%-7K
----
89.13%-5K
Interest expense - adjustment
----
----
----
--4.75M
----
----
----
----
----
----
Attributable subsidiary (profit) loss
----
----
----
-99.61%3K
----
17.90%764K
----
-67.42%648K
----
--1.99M
Impairment and provisions:
----
-32.29%3.54M
----
-55.09%5.23M
----
-46.51%11.65M
----
28,393.51%21.79M
----
-119.44%-77K
-Impairment of property, plant and equipment (reversal)
----
--215K
----
----
----
----
----
----
----
----
-Other impairments and provisions
----
-36.40%3.33M
----
-55.09%5.23M
----
-46.51%11.65M
----
28,393.51%21.79M
----
-119.44%-77K
Revaluation surplus:
----
-340.00%-638K
----
53.97%-145K
----
44.15%-315K
----
-184.81%-564K
----
156.50%665K
-Derivative financial instruments fair value (increase)
----
----
----
----
----
----
----
-215.71%-486K
----
137.63%420K
-Other fair value changes
----
-340.00%-638K
----
53.97%-145K
----
-303.85%-315K
----
-131.84%-78K
----
501.64%245K
Asset sale loss (gain):
----
101.28%322K
----
-52.57%-25.15M
----
---16.49M
----
----
----
---9.71M
-Loss (gain) from sale of subsidiary company
----
101.28%322K
----
-53.15%-25.15M
----
---16.42M
----
----
----
---9.71M
-Loss (gain) on sale of property, machinery and equipment
----
----
----
----
----
---62K
----
----
----
----
Depreciation and amortization:
----
-1.93%13.02M
----
-42.22%13.27M
----
-29.70%22.97M
----
-14.87%32.68M
----
49.06%38.38M
-Amortization of intangible assets
----
----
----
----
----
----
----
-24.56%86K
----
0.00%114K
Financial expense
----
-63.77%1.35M
----
-42.76%3.73M
----
-19.20%6.52M
----
-13.84%8.07M
----
74.33%9.37M
Special items
----
----
----
-92.15%821K
----
-39.23%10.46M
----
464.20%17.21M
----
-1,350.26%-4.73M
Operating profit before the change of operating capital
----
-65.86%6.35M
----
239.14%18.61M
----
-694.53%-13.37M
----
38.69%-1.68M
----
76.07%-2.75M
Change of operating capital
Inventory (increase) decrease
----
127.40%166K
----
-93.70%73K
----
-77.69%1.16M
----
103,980.00%5.19M
----
99.84%-5K
Accounts receivable (increase)decrease
----
-202.44%-4.34M
----
-125.89%-1.44M
----
12.49%5.55M
----
-75.69%4.93M
----
191.90%20.28M
Accounts payable increase (decrease)
----
165.71%14.59M
----
-435.08%-22.2M
----
1,480.21%6.63M
----
-116.97%-480K
----
-94.43%2.83M
Special items for working capital changes
----
----
----
----
----
----
----
0.00%1M
----
-70.81%1M
Cash  from business operations
----
438.20%16.76M
----
-11,700.00%-4.96M
----
-100.47%-42K
----
-58.04%8.96M
----
21.89%21.36M
Other taxs
----
----
----
----
----
----
----
---23K
----
----
Special items of business
-44.14%3.3M
----
33.63%5.91M
----
310.57%4.42M
----
71.40%-2.1M
----
55.75%-7.34M
----
Net cash from operations
-44.14%3.3M
438.20%16.76M
33.63%5.91M
-11,700.00%-4.96M
310.57%4.42M
-100.47%-42K
71.40%-2.1M
-58.15%8.94M
55.75%-7.34M
27.10%21.36M
Cash flow from investment activities
Interest received - investment
----
1,800.00%19K
----
-83.33%1K
----
-14.29%6K
----
40.00%7K
----
-89.13%5K
Loan receivable (increase) decrease
----
----
----
----
----
----
----
----
----
---3.57M
Sale of fixed assets
----
----
----
----
----
--220K
----
----
----
----
Purchase of fixed assets
----
73.29%-300K
----
1.40%-1.12M
----
70.85%-1.14M
----
73.93%-3.91M
----
76.54%-14.99M
Sale of subsidiaries
----
----
----
26.77%-93K
----
---127K
----
----
----
---928K
Recovery of cash from investments
----
--6.99M
----
----
----
----
----
--2M
----
----
Cash on investment
----
----
----
----
----
80.99%-230K
----
39.17%-1.21M
----
75.20%-1.99M
Other items in the investment business
70.89%-69K
----
18.56%-237K
99.76%-3K
63.85%-291K
56.94%-1.23M
-110.13%-805K
-102.48%-2.86M
5,467.57%7.94M
-215.16%-1.41M
Net cash from investment operations
70.89%-69K
650.99%6.71M
18.56%-237K
51.32%-1.22M
63.85%-291K
58.10%-2.5M
-110.13%-805K
73.91%-5.97M
5,467.57%7.94M
67.58%-22.88M
Net cash before financing
-43.02%3.23M
480.17%23.47M
37.30%5.67M
-142.69%-6.17M
242.20%4.13M
-185.74%-2.54M
-583.36%-2.91M
294.43%2.97M
103.59%601K
97.16%-1.53M
Cash flow from financing activities
New borrowing
----
502.41%1M
----
-98.89%166K
----
284.02%15M
----
113.79%3.91M
----
-91.75%1.83M
Refund
----
70.76%-9.4M
----
-291.61%-32.16M
----
14.49%-8.21M
----
-111.61%-9.61M
----
---4.54M
Issuing shares
----
----
----
4,792.24%51.08M
----
-92.86%1.04M
----
--14.62M
----
----
Interest paid - financing
----
23.81%-1.15M
----
51.21%-1.51M
----
59.69%-3.09M
----
14.86%-7.67M
----
-114.53%-9.01M
Absorb investment income
----
----
----
----
----
----
----
----
----
--2.21M
Issuance expenses and redemption of securities expenses
----
----
----
-3,563.04%-3.37M
----
28.68%-92K
----
---129K
----
----
Other items of the financing business
-6.94%-6.45M
----
-11.53%-6.04M
43.40%-60K
-388.13%-5.41M
---106K
3,582.35%1.88M
----
-99.51%51K
----
Adjustment item of financing business
----
----
----
----
----
----
----
----
----
--10M
Net cash from financing operations
-6.94%-6.45M
-604.36%-20.35M
-11.53%-6.04M
242.82%4.04M
-388.13%-5.41M
111.22%1.18M
3,582.35%1.88M
11.94%-10.49M
-99.51%51K
-133.38%-11.91M
Effect of rate
----
-99.79%5K
-99.92%1K
5,853.66%2.36M
45.24%1.25M
87.11%-41K
690.83%862K
-10,700.00%-318K
738.46%109K
-99.19%3K
Net Cash
-787.60%-3.22M
245.91%3.12M
71.64%-363K
-56.47%-2.14M
-24.63%-1.28M
81.83%-1.37M
-257.52%-1.03M
44.02%-7.52M
110.41%652K
25.71%-13.44M
Begining period cash
369.50%3.97M
35.14%846K
35.14%846K
-69.22%626K
-69.22%626K
-79.40%2.03M
-79.40%2.03M
-57.64%9.88M
-57.64%9.88M
-43.19%23.31M
Cash at the end
54.96%750K
369.50%3.97M
-19.06%484K
35.14%846K
-68.00%598K
-69.22%626K
-82.43%1.87M
-79.40%2.03M
-37.65%10.64M
-57.64%9.88M
Cash balance analysis
Cash and bank balance
----
----
----
----
----
----
----
----
--10.64M
----
Currency Unit
HKD
HKD
HKD
HKD
HKD
HKD
HKD
HKD
HKD
HKD
Accounting Standards
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
Audit Opinions
--
--
--
--
--
--
--
--
--
Unqualified Opinion
Auditor
--
--
--
--
--
--
--
--
--
National Health Accounting Firm Co., Ltd.
(Q6)Jun 30, 2025(FY)Dec 31, 2024(Q6)Jun 30, 2024(FY)Dec 31, 2023(Q6)Jun 30, 2023(FY)Dec 31, 2022(Q6)Jun 30, 2022(FY)Dec 31, 2021(Q6)Jun 30, 2021(FY)Dec 31, 2020
Cash flow from operating activities
Earning before tax -----169.34%-11.16M----132.88%16.09M----39.96%-48.94M-----111.00%-81.51M----8.34%-38.63M
Profit adjustment
Interest (income) - adjustment -----8,700.00%-88K----83.33%-1K----14.29%-6K-----40.00%-7K----89.13%-5K
Interest expense - adjustment --------------4.75M------------------------
Attributable subsidiary (profit) loss -------------99.61%3K----17.90%764K-----67.42%648K------1.99M
Impairment and provisions: -----32.29%3.54M-----55.09%5.23M-----46.51%11.65M----28,393.51%21.79M-----119.44%-77K
-Impairment of property, plant and equipment (reversal) ------215K--------------------------------
-Other impairments and provisions -----36.40%3.33M-----55.09%5.23M-----46.51%11.65M----28,393.51%21.79M-----119.44%-77K
Revaluation surplus: -----340.00%-638K----53.97%-145K----44.15%-315K-----184.81%-564K----156.50%665K
-Derivative financial instruments fair value (increase) -----------------------------215.71%-486K----137.63%420K
-Other fair value changes -----340.00%-638K----53.97%-145K-----303.85%-315K-----131.84%-78K----501.64%245K
Asset sale loss (gain): ----101.28%322K-----52.57%-25.15M-------16.49M---------------9.71M
-Loss (gain) from sale of subsidiary company ----101.28%322K-----53.15%-25.15M-------16.42M---------------9.71M
-Loss (gain) on sale of property, machinery and equipment -----------------------62K----------------
Depreciation and amortization: -----1.93%13.02M-----42.22%13.27M-----29.70%22.97M-----14.87%32.68M----49.06%38.38M
-Amortization of intangible assets -----------------------------24.56%86K----0.00%114K
Financial expense -----63.77%1.35M-----42.76%3.73M-----19.20%6.52M-----13.84%8.07M----74.33%9.37M
Special items -------------92.15%821K-----39.23%10.46M----464.20%17.21M-----1,350.26%-4.73M
Operating profit before the change of operating capital -----65.86%6.35M----239.14%18.61M-----694.53%-13.37M----38.69%-1.68M----76.07%-2.75M
Change of operating capital
Inventory (increase) decrease ----127.40%166K-----93.70%73K-----77.69%1.16M----103,980.00%5.19M----99.84%-5K
Accounts receivable (increase)decrease -----202.44%-4.34M-----125.89%-1.44M----12.49%5.55M-----75.69%4.93M----191.90%20.28M
Accounts payable increase (decrease) ----165.71%14.59M-----435.08%-22.2M----1,480.21%6.63M-----116.97%-480K-----94.43%2.83M
Special items for working capital changes ----------------------------0.00%1M-----70.81%1M
Cash  from business operations ----438.20%16.76M-----11,700.00%-4.96M-----100.47%-42K-----58.04%8.96M----21.89%21.36M
Other taxs -------------------------------23K--------
Special items of business -44.14%3.3M----33.63%5.91M----310.57%4.42M----71.40%-2.1M----55.75%-7.34M----
Net cash from operations -44.14%3.3M438.20%16.76M33.63%5.91M-11,700.00%-4.96M310.57%4.42M-100.47%-42K71.40%-2.1M-58.15%8.94M55.75%-7.34M27.10%21.36M
Cash flow from investment activities
Interest received - investment ----1,800.00%19K-----83.33%1K-----14.29%6K----40.00%7K-----89.13%5K
Loan receivable (increase) decrease ---------------------------------------3.57M
Sale of fixed assets ----------------------220K----------------
Purchase of fixed assets ----73.29%-300K----1.40%-1.12M----70.85%-1.14M----73.93%-3.91M----76.54%-14.99M
Sale of subsidiaries ------------26.77%-93K-------127K---------------928K
Recovery of cash from investments ------6.99M----------------------2M--------
Cash on investment --------------------80.99%-230K----39.17%-1.21M----75.20%-1.99M
Other items in the investment business 70.89%-69K----18.56%-237K99.76%-3K63.85%-291K56.94%-1.23M-110.13%-805K-102.48%-2.86M5,467.57%7.94M-215.16%-1.41M
Net cash from investment operations 70.89%-69K650.99%6.71M18.56%-237K51.32%-1.22M63.85%-291K58.10%-2.5M-110.13%-805K73.91%-5.97M5,467.57%7.94M67.58%-22.88M
Net cash before financing -43.02%3.23M480.17%23.47M37.30%5.67M-142.69%-6.17M242.20%4.13M-185.74%-2.54M-583.36%-2.91M294.43%2.97M103.59%601K97.16%-1.53M
Cash flow from financing activities
New borrowing ----502.41%1M-----98.89%166K----284.02%15M----113.79%3.91M-----91.75%1.83M
Refund ----70.76%-9.4M-----291.61%-32.16M----14.49%-8.21M-----111.61%-9.61M-------4.54M
Issuing shares ------------4,792.24%51.08M-----92.86%1.04M------14.62M--------
Interest paid - financing ----23.81%-1.15M----51.21%-1.51M----59.69%-3.09M----14.86%-7.67M-----114.53%-9.01M
Absorb investment income --------------------------------------2.21M
Issuance expenses and redemption of securities expenses -------------3,563.04%-3.37M----28.68%-92K-------129K--------
Other items of the financing business -6.94%-6.45M-----11.53%-6.04M43.40%-60K-388.13%-5.41M---106K3,582.35%1.88M-----99.51%51K----
Adjustment item of financing business --------------------------------------10M
Net cash from financing operations -6.94%-6.45M-604.36%-20.35M-11.53%-6.04M242.82%4.04M-388.13%-5.41M111.22%1.18M3,582.35%1.88M11.94%-10.49M-99.51%51K-133.38%-11.91M
Effect of rate -----99.79%5K-99.92%1K5,853.66%2.36M45.24%1.25M87.11%-41K690.83%862K-10,700.00%-318K738.46%109K-99.19%3K
Net Cash -787.60%-3.22M245.91%3.12M71.64%-363K-56.47%-2.14M-24.63%-1.28M81.83%-1.37M-257.52%-1.03M44.02%-7.52M110.41%652K25.71%-13.44M
Begining period cash 369.50%3.97M35.14%846K35.14%846K-69.22%626K-69.22%626K-79.40%2.03M-79.40%2.03M-57.64%9.88M-57.64%9.88M-43.19%23.31M
Cash at the end 54.96%750K369.50%3.97M-19.06%484K35.14%846K-68.00%598K-69.22%626K-82.43%1.87M-79.40%2.03M-37.65%10.64M-57.64%9.88M
Cash balance analysis
Cash and bank balance ----------------------------------10.64M----
Currency Unit HKDHKDHKDHKDHKDHKDHKDHKDHKDHKD
Accounting Standards HKASHKASHKASHKASHKASHKASHKASHKASHKASHKAS
Audit Opinions ------------------Unqualified Opinion
Auditor ------------------National Health Accounting Firm Co., Ltd.

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
China and the US begin implementing the Kuala Lumpur economic and trade consultation consensus.
China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome Show More